Sunday, November 11, 2012

Nuclear Medicine: Low-Dose Molecular Breast Imaging Evaluated in the Detection of Breast Cancer

Breast-specific gamma imaging (BSGI), also known as molecular breast imaging (MBI), is a modality that identifies breast tumors overlooked by ultrasound and mammography, especially in women with dense breasts.

Thursday, November 8, 2012

Ultrasound: Treatment Planning System Updated for Real-Time Ultrasound-Guided Prostate Cancer Brachytherapy

A new partnership agreement between Siemens Healthcare (Erlangen, Germany) and Varian Medical Systems (Palo Alto, CA, USA) has been established to advance radiation treatment planning and delivery technology.

Tuesday, November 6, 2012

General Imaging: Prospective Drawbacks Seen in Cost-Cuts for Medical Imaging Scans

A new report revealed that the timespan of the average hospital stay in the United States has risen at the same time as medical imaging use has dropped. It is not yet known if the trends are linked, but these new findings may be significant, because hospital admissions are among the fastest growing and largest healthcare costs.

Monday, November 5, 2012

Nuclear Medicine: Improved possibilities of proton therapy to patient

A new patient-centric proton therapy room has been designed to stimulate patient comfort during proton treatments by allowing patients to selectively add relaxing sound, light, and images to the treatment room environment before they initiate therapy.

Sunday, November 4, 2012

General Imaging: New diagnostic displays developed for radiologists

New diagnostic displays developed for radiologists offer three times the resolution of monochrome liquid crystal displays (LCDs), improving visualization for help in critical diagnoses. Sony Electronics’ medical systems division

Saturday, November 3, 2012

MRI: MR-Conditional Pacemaker System Approved in Japan

With the use of new magnetic resonance imaging (MRI)-conditional pacing technology, pacemaker patients will have access to full body scanners, without positioning restriction in the MRI scanner.

Thursday, November 1, 2012

Radiography: A new agent has been developed to treat radiation exposure.

A new agent that is similar to a naturally occurring molecule found in blueberries and coffee has been developed to treat radiation exposure.

Wednesday, October 31, 2012

Nuclear Medicine: PET Radiopharmaceutical Receives European Endorsement for Imaging of β-Amyloid Density

A European health agency has recommended marketing authorization for Amyvid (florbetapir 18F) as a diagnostic imaging agent in patients who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.

Monday, October 29, 2012

Radiography: 3D CT Breast Cancer Scanning Technology

Newly developed technology provides three-dimensional (3D) X-ray imaging of the breast with a radiation dose that is lower than the current 2D X-ray imaging used in clinics.

Sunday, October 28, 2012

MRI: MRI Proves Effective Guiding Heart Catheter Procedures

Heart catheter procedures guided by magnetic resonance imaging (MRI) are as safe as X-ray-guided procedures and do not take any longer, according to a pilot study.

Thursday, October 25, 2012

Men's Health: Task Force Recommends Against Hormone Replacement Therapy for Postmenopausal Women

The United States Preventive Services Task Force recommends against the use of estrogen and progestin for the prevention of chronic medical conditions in postmenopausal women

Wednesday, October 24, 2012

Imaging IT: New DICOM Guard Technology for high patient Data safety

A new Digital Imaging and Communications in Medicine (DICOM) application features proprietary data tagging technology, which allows healthcare enterprises to have complete control over security of their patient data.

Monday, October 22, 2012

Ultrasound: Collaborative Efforts to Develop Medical Ultrasound Practice Guidelines

American medical societies have collaborated on a guideline that comprises indications for an ultrasound examination for a focused reproductive endocrinology and infertility scan.

Sunday, October 21, 2012

Nuclear Medicine: The specificity and overall accuracy of F-18-FLT were considerably higher than F-18-FDG PET both during and after radiation therapy.

Determining the optimal treatment course and predicting outcomes may soon become simpler for head and neck sqaumous cell carcinomas (HNSCCs) patients with the use of a new investigational imaging agent.

Friday, October 19, 2012

Psoriasis: Investigation found a clear association between psoriasis and diabetes

An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.

Wednesday, October 17, 2012

Nuclear Medicine: New Radiation Treatment Significantly Increases Survival Rate

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D.,

Monday, October 15, 2012

Cosmetic Medicine: Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies

Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies, and could hold the key to maintaining a youthful appearance, according to scientists at Queen Mary, University of London.

Sunday, October 14, 2012

Drinking alcohol and smoking have to throw together

New research verifies previous studies by Dr. Timothy Durazzo and his colleagues, showing that smoking, while trying to quit drinking alcohol, impairs learning, memory, and other cognitive skills, hindering successful sobriety.

Wednesday, October 10, 2012

Value-based pricing is one potential solution to reduce the cost of drugs

A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.

Tuesday, October 9, 2012

Subcutaneous Formulation Of ORENCIA® (Abatacept) Approved By European Commission

Bristol-Myers Squibb have announced that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of adults with moderate to severe active rheumatoid arthritis (RA).